Related Experiment Videos

Androgen receptor-mediated regulation of the anti-atherogenic enzyme CYP27A1 involves the JNK/c-jun pathway

Maria Norlin1, Hanna Pettersson, Wanjin Tang

  • 1Department of Pharmaceutical Biosciences, Division of Biochemistry, University of Uppsala, Box 578, S-75123 Uppsala, Sweden.

Archives of Biochemistry and Biophysics
|December 8, 2010
PubMed

Insights

The study reveals the JNK/c-jun pathway regulates CYP27A1, an enzyme crucial for cholesterol and vitamin D metabolism. This pathway is essential for androgen receptor-mediated increases in CYP27A1 activity, offering insights into cholesterol clearance.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • CYP27A1 plays key roles in cholesterol homeostasis and vitamin D₃ metabolism.
  • CYP27A1 exhibits anti-atherogenic properties, making its regulation a significant area of study.
  • Previous research indicated androgen receptor (AR)-mediated upregulation of CYP27A1.

Purpose of the Study:

  • To investigate the regulatory mechanisms of the human CYP27A1 gene.
  • To identify the role of the JNK/c-jun pathway in CYP27A1 regulation.
  • To elucidate the interplay between the AR and JNK/c-jun pathway in controlling CYP27A1 expression.

Main Methods:

  • Analysis of CYP27A1 promoter activity using JNK inhibitors and overexpression.
  • Assessment of AR antagonist nilutamide's effect on androgen-induced CYP27A1.
  • Investigating the impact of JNK pathway modulation on AR-mediated CYP27A1 transcription and enzyme activity.

Main Results:

  • The JNK/c-jun pathway was identified as a novel regulator of the human CYP27A1 gene.
  • Inhibition of JNK signaling downregulated basal CYP27A1 promoter activity.
  • The JNK/c-jun pathway was found to be critical for AR-mediated upregulation of CYP27A1, with JNK overexpression enhancing this effect.

Conclusions:

  • The JNK/c-jun pathway is involved in the AR-mediated upregulation of human CYP27A1.
  • This finding links inflammatory processes, which can activate JNK signaling, to potential upregulation of CYP27A1 for cholesterol clearance.
  • Understanding this regulatory axis provides new insights into managing cholesterol metabolism and atherosclerosis.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...